ArticleRSC advances2025
Engineered carbon electrode with graphene-cyclodextrin/ferrocenyl-carnosine nanoassembly for Mn(ii) detection.
Article in RSC advances, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- A portable multimodal electrochemical platform integrating β-cyclodextrin and Pd-Au@ZnO nanostructures for the chiral recognition of valine enantiomers in complex biological matrices.Analytical and bioanalytical chemistry · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The modification of electrodes using carbon-based nanomaterials is an efficient strategy for enhancing their electrical conductivity and working surface area. In this study, we explore the ability of a screen-printed carbon electrode (SPCE) modified with graphene-cyclodextrin/ferrocenyl-carnosine (GCD/FcCAR) supramolecular assembly for the determination of Mn(ii) in an aqueous solution. Although Mn(ii) is an essential nutrient for humans, it can be toxic at elevated levels, leading to neurotoxic symptoms. Consequently, accurate analytical determination is necessary. The graphene platform (G-Alk) was derivatized with mono-6-deoxy-6-azido-β-cyclodextrin (CD)
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.